Joel M Dulhunty1, Jeffrey Lipman, Simon Finfer. 1. Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, and Burns, Trauma and Critical Care Research Centre, University of Queensland, Herston, QLD, 4029, Australia. Joel_Dulhunty@health.qld.gov.au
Abstract
OBJECTIVE: To compare the time course of organ dysfunction/failure, mortality and cause of death in patients with severe sepsis (SS) and patients with severe non-infectious systemic inflammatory response syndrome (SNISIRS). DESIGN: Secondary analysis of a multi-centre inception cohort study. SETTING: Twenty-three multidisciplinary intensive care units (ICUs) in Australia and New Zealand. PATIENTS AND PARTICIPANTS: 3,543 ICU admissions > or = 48 h or <48 h if SIRS and organ dysfunction present. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: ICU prevalence of SS and SNISIRS was 20% (707/3,543) and 28% (980/3,543), respectively. ICU mortality was similar in patients with SNISIRS and with SS (25 vs. 27%, P = 0.40). Central nervous system (CNS) failure occurred more frequently in patients with SNISIRS (33 vs. 22%, P < 0.001) and resulted in death more commonly than in SS (relative risk = 1.6, 95% confidence interval 1.4-1.7, P < 0.001). The time to peak organ dysfunction (0.67 vs. 0.91 days, P = 0.004), overall episode length (3.6 vs. 5.6 days, P < 0.001) and ICU stay (geometric mean: 4.1 vs. 5.8 days, P < 0.001) were significantly shorter in patients with SNISIRS. CONCLUSIONS: Whilst SNISIRS and SS have similarities, including their crude mortality rate, important differences exist. SNISIRS is more common on admission to the ICU, and is more commonly coupled with CNS dysfunction and death from neurological failure. DESCRIPTORS: SIRS/sepsis: clinical studies.
OBJECTIVE: To compare the time course of organ dysfunction/failure, mortality and cause of death in patients with severe sepsis (SS) and patients with severe non-infectious systemic inflammatory response syndrome (SNISIRS). DESIGN: Secondary analysis of a multi-centre inception cohort study. SETTING: Twenty-three multidisciplinary intensive care units (ICUs) in Australia and New Zealand. PATIENTS AND PARTICIPANTS: 3,543 ICU admissions > or = 48 h or <48 h if SIRS and organ dysfunction present. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: ICU prevalence of SS and SNISIRS was 20% (707/3,543) and 28% (980/3,543), respectively. ICU mortality was similar in patients with SNISIRS and with SS (25 vs. 27%, P = 0.40). Central nervous system (CNS) failure occurred more frequently in patients with SNISIRS (33 vs. 22%, P < 0.001) and resulted in death more commonly than in SS (relative risk = 1.6, 95% confidence interval 1.4-1.7, P < 0.001). The time to peak organ dysfunction (0.67 vs. 0.91 days, P = 0.004), overall episode length (3.6 vs. 5.6 days, P < 0.001) and ICU stay (geometric mean: 4.1 vs. 5.8 days, P < 0.001) were significantly shorter in patients with SNISIRS. CONCLUSIONS: Whilst SNISIRS and SS have similarities, including their crude mortality rate, important differences exist. SNISIRS is more common on admission to the ICU, and is more commonly coupled with CNS dysfunction and death from neurological failure. DESCRIPTORS: SIRS/sepsis: clinical studies.
Authors: Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis Journal: N Engl J Med Date: 2006-08-14 Impact factor: 91.245
Authors: Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams Journal: Crit Care Med Date: 2005-10 Impact factor: 7.598
Authors: J A Russell; J Singer; G R Bernard; A Wheeler; W Fulkerson; L Hudson; R Schein; W Summer; P Wright; K R Walley Journal: Crit Care Med Date: 2000-10 Impact factor: 7.598
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Intensive Care Med Date: 2003-03-28 Impact factor: 17.440
Authors: Charles L Sprung; Yasser Sakr; Jean-Louis Vincent; Jean-Roger Le Gall; Konrad Reinhart; V Marco Ranieri; Herwig Gerlach; Jonathan Fielden; C B Groba; Didier Payen Journal: Intensive Care Med Date: 2006-02-15 Impact factor: 17.440
Authors: Bruno Adler Maccagnan Pinheiro Besen; André Luiz Nunes Gobatto; Lívia Maria Garcia Melro; Alexandre Toledo Maciel; Marcelo Park Journal: World J Crit Care Med Date: 2015-05-04
Authors: Francis Schneider; Charlotte Bach; Hélène Chung; Luca Crippa; Thomas Lavaux; Pierre-Edouard Bollaert; Michel Wolff; Angelo Corti; Anne Launoy; Xavier Delabranche; Thierry Lavigne; Nicolas Meyer; Patrick Garnero; Marie-Hélène Metz-Boutigue Journal: Intensive Care Med Date: 2012-06-16 Impact factor: 17.440
Authors: František Novak; J Borovska; M Vecka; J Rychlikova; L Vavrova; H Petraskova; A Zak; O Novakova Journal: Lipids Date: 2016-12-30 Impact factor: 1.880
Authors: Michael M Liao; Dennis Lezotte; Steven R Lowenstein; Kevin Howard; Zachary Finley; Zipei Feng; Richard L Byyny; Jeffrey D Sankoff; Ivor S Douglas; Jason S Haukoos Journal: Am J Emerg Med Date: 2014-08-08 Impact factor: 2.469
Authors: Alex Smithson; Rafael Perello; Jesus Aibar; Gerard Espinosa; Dolors Tassies; Carolina Freire; Pedro Castro; Belen Suarez; Francisco Lozano; Josep-Maria Nicolas Journal: Clin Vaccine Immunol Date: 2009-12-30
Authors: Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney Journal: Intensive Care Med Date: 2010-07-15 Impact factor: 17.440